Ortho Dermatologics, Inc. Sustainability Profile
Ortho Dermatologics, Inc., a prominent player in the dermatological industry, is headquartered in the United States and operates extensively across North America. Founded in 2013, the company has quickly established itself as a leader in the development and marketing of innovative dermatological products, focusing on conditions such as psoriasis, acne, and eczema. With a diverse portfolio that includes prescription medications and over-the-counter solutions, Ortho Dermatologics is recognised for its commitment to quality and efficacy. The company’s unique approach combines advanced research with patient-centric solutions, ensuring that their offerings meet the evolving needs of healthcare professionals and patients alike. Notable achievements include strategic partnerships and a growing market presence, solidifying Ortho Dermatologics' position as a trusted name in dermatology.
DitchCarbon Score
How does Ortho Dermatologics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ortho Dermatologics, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ortho Dermatologics, Inc.'s reported carbon emissions
Ortho Dermatologics, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Bausch Health Companies Inc., and any emissions data or climate commitments would be inherited from this parent organisation. As of now, there are no documented reduction targets or climate pledges specific to Ortho Dermatologics. However, it is important to note that the climate initiatives and performance metrics may be influenced by Bausch Health Companies Inc., which operates under various sustainability frameworks, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). Given the absence of specific emissions data and reduction targets, Ortho Dermatologics' climate commitments remain vague. The company may align with broader industry standards and practices as dictated by its parent organisation, but detailed information on their specific initiatives or performance is not currently available.
How Carbon Intensive is Ortho Dermatologics, Inc.'s Industry?
How Carbon Intensive is Ortho Dermatologics, Inc.'s Location?
Ortho Dermatologics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ortho Dermatologics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
